Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUDG.L Share News (UDG)

  • There is currently no data for UDG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: Energy and Financials wanted, Meggitt downgraded

Wed, 11th Nov 2020 15:37

(Sharecast News) - Energy and Financials paced gains on the second-tier index on Wednesday as investors continued to shift towards cyclicals after Pfizer and BioNTech announced two days before a greater than 90% efficacy for the Covid-19 vaccine.
For some observers, such high degrees of efficacy could open the door to achieving herd immunity in populations and pave the way for a full reopening of economies.

Tied to that news, front month Brent crude oil futures were adding 1.83% to $44.41 a barrel on ICE.

In their wake, James Fisher&Sons, the specialist marine services outfit, and Energean, the Mediterranean-focused oil explorer were both near the top of the leaderboard.

Financials including Investec, Capita, Virgin Money UK and CMC Markets UK were all well bid alongside.

Airtel Africa was also outperforming, with its shares trading just off their record highs.

UDG Healthcare was also wanted, after RBC upgraded the shares to 'outperform', with the analysts citing the stock's recent underperformance versus peers' as the key rationale for their decision.

"The 20%-plus underperformance of UDG vs its peers, the prospect of two years of mid-teens earnings growth, and its strong balance sheet leads us to increase our price target to 880p (11.7x EBITDA, based on a SOP approach), from 800p, and move to an Outperform rating, from Sector Perform."



Going the other way, Meggitt was lower after analysts at SocGen downgraded their recommendation for the stock to 'sell'.

The day before, the engineer had reinstated its full-year 2020 guidance, a move which the broker labelled "encouraging".

However, while the improvement in its full year cash flow should alleviate concerns around its balance sheet, "the EBIT guidance range is wide".

"Although a COVID-19 vaccine could accelerate the civil spares recovery, we think new aircraft deliveries are unlikely to reach the pre-COVID levels for quite some time," it said.

SocGen had a 309.0p target price on the shares, up from 306.0p before.



Market Movers

FTSE 250 (MCX) 19,355.62 1.72%


FTSE 250 - Risers

Quilter (QLT) 138.85p 0.00%
VinaCapital Vietnam Opportunity Fund Ltd. (VOF) 352.50p 0.00%
Scottish Inv Trust (SCIN) 735.00p 0.00%
Frasers Group (FRAS) 459.20p 0.00%
Sabre Insurance Group (SBRE) 248.00p 0.00%
Vesuvius (VSVS) 472.20p 0.00%
Fidelity Special Values (FSV) 211.00p 0.00%
Alternative Credit Investments (ACI) 880.00p 0.00%
TR Property Inv Trust (TRY) 381.00p 0.00%
Bodycote (BOY) 763.00p 0.00%

FTSE 250 - Fallers

Quilter (QLT) 138.85p 0.00%
VinaCapital Vietnam Opportunity Fund Ltd. (VOF) 352.50p 0.00%
Scottish Inv Trust (SCIN) 735.00p 0.00%
Frasers Group (FRAS) 459.20p 0.00%
Sabre Insurance Group (SBRE) 248.00p 0.00%
Vesuvius (VSVS) 472.20p 0.00%
Fidelity Special Values (FSV) 211.00p 0.00%
Alternative Credit Investments (ACI) 880.00p 0.00%
TR Property Inv Trust (TRY) 381.00p 0.00%
Bodycote (BOY) 763.00p 0.00%
More News
1 Dec 2016 09:31

BROKER RATINGS SUMMARY: Credit Suisse Raises BP To Outperform

Read more
25 Nov 2016 20:13

FTSE 250 movers: Paragon Group jumps, AMEC sinks

(ShareCast News) - Paragon Group led to the upside on the back of a positive endorsement from broker Jefferies. Analyst Phil Dobbin said: "Paragon is evolving from a securitized non-bank lender to a more diversified retail funded banking group. We believe that the company has the ability to gain mar

Read more
25 Nov 2016 16:42

Sector movers: Defensives pace gains

(ShareCast News) - Defensive issues and so-called 'bond proxies' performed best at the tail-end of the week, with shares of personal goods and health care equipment companies pacing gains. Among the former of those two sectors, it was Unilever which did best after the manufacturer said it would appe

Read more
24 Nov 2016 09:38

UDG Healthcare poised for future growth after disposals

(ShareCast News) - UDG Healthcare is in a net cash position to deliver sustained future growth after the disposal of its United Drug Supply Chain (UDSC) businesses and MASTA. The group's disposal of the (UDSC) businesses and MASTA completed on 1 April 2016 resulted in a net profit of €132.1m. Net

Read more
18 Nov 2016 18:17

Friday broker round-up

(ShareCast News) - Tesco: HSBC reiterates buy with a target price of 260p. Sage: Goldman Sachs reiterates buy with a 870p target. Aggreko: Barclays stays at overweight with a 1000p target. Prudential: Barclays reiterates overweight with a 1748p target. IQE: Canaccord keeps at buy with a 51p targe

Read more
21 Oct 2016 11:10

UDG Healthcare buys STEM Marketing for up to £84m

(ShareCast News) - UDG Healthcare has acquired STEM Marketing, a provider of commercial, marketing and medical audits to pharmaceutical companies, for up to £84m in a deal that is expected to be immediately accretive to earnings. The FTSE 250 provider of healthcare services said STEM is a highly cas

Read more
26 Sep 2016 14:40

CEO of UDG Healthcare's Ashfield division to retire

(ShareCast News) - UDG Healthcare said on Monday that Chris Corbin, the chief executive officer of its largest division, Ashfield Commercial & Medical Services, will retire in April 2019. In preparation for his retirement, Corbin will transition to the role of chairman of Ashfield once his successo

Read more
4 Aug 2016 08:57

UDG Healthcare reports rise in quarterly revenues

(ShareCast News) - UDG Healthcare's revenues and adjusted operating profits in the nine months to 30 June were well ahead of the previous year, according to a trading statement on Thursday. Operating profit growth in the nine months to June was driven by strong underlying profit growth in its Sharp

Read more
3 Jun 2016 16:10

DIRECTOR DEALINGS: UDG Healthcare CEO Buys 30,000 Shares

Read more
19 May 2016 08:56

UDG reports on a healthy first half

(ShareCast News) - International healthcare services provider UDG reported a first half of "financial and strategic progress" on Thursday, with adjusted revenue growing 2% at constant currencies to €472.4m. The FTSE 250 firm's adjusted operating profit in the six months to 31 March improved 9% at co

Read more
19 May 2016 07:38

UDG Reiterates Earnings Guidance After Profit Rises In First Half

Read more
12 May 2016 15:18

Earnings, Trading Statements Calendar - Week Ahead

Read more
1 Apr 2016 06:37

UDG Healthcare Completes United Drug Supply, MASTA Unit Sales

Read more
4 Mar 2016 15:54

EU mergers and takeovers (March 4)

BRUSSELS, March 4 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS -- French company Avril Pole Animal and German meat product processor Tonnies International Holding to set up a joint v

Read more
4 Mar 2016 08:19

UDG Healthcare disposal clears regulatory hurdle

(ShareCast News) - UDG Healthcare's proposed sale of two of its businesses to McKesson Corporation has made it over a significant regulatory hurdle, the company revealed on Friday. The FTSE 250 company had announced details of the sale of United Drug Supply and MASTA on 18 September and 13 October 2

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.